Mark H. Pollack

Active 1989–2025

119
Papers
18,991
Citations
87
h-index
118
i10-index

Citations

Citations per year for Mark H. Pollack1952: 2 citations1955: 1 citations1991: 3 citations1993: 4 citations1994: 9 citations1995: 9 citations1996: 7 citations1997: 10 citations1998: 16 citations1999: 18 citations2000: 39 citations2001: 40 citations2002: 62 citations2003: 46 citations2004: 85 citations2005: 110 citations2006: 123 citations2007: 161 citations2008: 201 citations2009: 173 citations2010: 184 citations2011: 178 citations2012: 175 citations2013: 198 citations2014: 226 citations2015: 192 citations2016: 173 citations2017: 132 citations2018: 144 citations2019: 339 citations2020: 402 citations2021: 271 citations2022: 245 citations2023: 144 citations2024: 222 citations2025: 99 citations2026: 1 citations1953–1954: no citations, so these years are not shown1956–1990: no citations, so these years are not shown1992: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,979 citing papers, 37.6% of this breakdownUnited Kingdom: 414 citing papers, 7.9% of this breakdownGermany: 297 citing papers, 5.6% of this breakdownCanada: 279 citing papers, 5.3% of this breakdownItaly: 216 citing papers, 4.1% of this breakdownAustralia: 192 citing papers, 3.6% of this breakdownChina: 184 citing papers, 3.5% of this breakdownNetherlands: 157 citing papers, 3% of this breakdownBrazil: 117 citing papers, 2.2% of this breakdownSwitzerland: 105 citing papers, 2% of this breakdownSpain: 105 citing papers, 2% of this breakdownFrance: 103 citing papers, 2% of this breakdown
0%37.6%Other 21.2%

Fields

  • Psychology34.4%
  • Medicine33%
  • Neuroscience24.7%
  • Biochemistry, Genetics and Molecular Biology3.3%
  • Computer Science1.1%
  • Health Professions0.9%
  • Other2.6%

Topics

  • Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes6.5%
  • Treatment of Major Depression4.6%
  • Tryptophan and brain disorders4.5%
  • Stress Responses and Cortisol4.4%
  • Bipolar Disorder and Treatment3.4%
  • Child and Adolescent Psychosocial and Emotional Development2.6%
  • Other74%

Coauthors

All papers

Open in search
  1. A pilot study of vagus nerve stimulation (VNS) for treatment-resistant anxiety disorders

    Authors: , , , , , , , , , - Brain stimulation 2008 cited by 251

  2. Brain connectomics predict response to treatment in social anxiety disorder

    Authors: , , , , , , , , , - Molecular Psychiatry 2015 cited by 216

  3. RESEARCH: Validation of the Massachusetts General Hospital Antidepressant Treatment History Questionnaire (ATRQ)

    Authors: , , , , - CNS Neuroscience & Therapeutics 2009 cited by 156

  4. Reliability and validity of a structured interview guide for the Hamilton Anxiety Rating Scale (SIGH-A)

    Authors: , , , , , , , , , , - Depression and Anxiety 2001 cited by 478

  5. D-Cycloserine Augmentation of Exposure-Based Cognitive Behavior Therapy for Anxiety, Obsessive-Compulsive, and Posttraumatic Stress Disorders

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eric A. Storch, Andreas Ströhle, Candyce D. Tart, David F. Tolin, Agnes van Minnen, Allison M. Waters, Carl F. Weems, Sabine Wilhelm, Katarzyna Wyka, Michael Davis, Christian Rück, Margaret Altemus, Page L. Anderson, Judith Cukor, Claudia Finck, Gary R. Geffken, Fabian Golfels, Wayne K. Goodman, Cassidy A. Gutner, Isobel Heyman, Tanja Jovanović, Adam B. Lewin, Joseph P. H. McNamara, Tanya K. Murphy, Seth D. Norrholm, Paul Thuras - JAMA Psychiatry 2017 cited by 292

  6. Randomized Controlled Trial of Mindfulness Meditation for Generalized Anxiety Disorder

    Authors: , , , , , , , , - The Journal of Clinical Psychiatry 2013 cited by 510

  7. Comorbid anxiety and depression.

    Authors: - 2005 cited by 221

  8. Abnormal intestinal milieu in posttraumatic stress disorder is not impacted by treatment that improves symptoms

    Authors: , , , , , , , , , - American Journal of Physiology-Gastrointestinal and Liver Physiology 2022 cited by 26

  9. Broad spectrum of cytokine abnormalities in panic disorder and posttraumatic stress disorder

    Authors: , , , , , - Depression and Anxiety 2009 cited by 350

  10. The effect of mindfulness meditation training on biological acute stress responses in generalized anxiety disorder

    Authors: , , , , , , , - Psychiatry Research 2017 cited by 196

  11. Eszopiclone Coadministered With Escitalopram in Patients With Insomnia and Comorbid Generalized Anxiety Disorder

    Authors: , , , , , , , , , - Archives of General Psychiatry 2008 cited by 158

  12. Placebo-Controlled Study of Gabapentin Treatment of Panic Disorder

    Authors: , , , , , , , , - Journal of Clinical Psychopharmacology 2000 cited by 281

  13. Predicting Treatment Response in Social Anxiety Disorder From Functional Magnetic Resonance Imaging

    Authors: , , , , , , , , , , , - JAMA Psychiatry 2012 cited by 265

  14. Oxytocin Levels in Social Anxiety Disorder

    Authors: , , , , - CNS Neuroscience & Therapeutics 2008 cited by 216

  15. Anxiety Disorder Comorbidity in Bipolar Disorder Patients: Data From the First 500 Participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)

    Authors: , , , , , , , , , , - American Journal of Psychiatry 2004 cited by 561

  16. Cognitive-behavioral and pharmacological treatment for social phobia: A meta-analysis.

    Authors: , , , , - Clinical Psychology Science and Practice 1997 cited by 444

  17. Resilience: research evidence and conceptual considerations for posttraumatic stress disorder

    Authors: , , - Depression and Anxiety 2006 cited by 328

  18. A detailed examination of cytokine abnormalities in Major Depressive Disorder

    Authors: , , , , , , , , - European Neuropsychopharmacology 2007 cited by 287

  19. Pregabalin for Treatment of Generalized Anxiety Disorder

    Authors: , , , , , , , , , - Archives of General Psychiatry 2005 cited by 281

  20. Paroxetine CR Augmentation for Posttraumatic Stress Disorder Refractory to Prolonged Exposure Therapy

    Authors: , , , , , , , , , , - The Journal of Clinical Psychiatry 2008 cited by 126

  21. CORTICO-LIMBIC RESPONSES TO MASKED AFFECTIVE FACES ACROSS PTSD, PANIC DISORDER, AND SPECIFIC PHOBIA

    Authors: , , , , , , , , , - Depression and Anxiety 2013 cited by 119

  22. High-field MRS study of GABA, glutamate and glutamine in social anxiety disorder: Response to treatment with levetiracetam

    Authors: , , , , - Progress in Neuro-Psychopharmacology and Biological Psychiatry 2007 cited by 114

  23. Augmentation of Exposure Therapy With D-Cycloserine for Social Anxiety Disorder

    Authors: , , , , , , , - Archives of General Psychiatry 2006 cited by 566

  24. Telomere Shortening and Mood Disorders: Preliminary Support for a Chronic Stress Model of Accelerated Aging

    Authors: , , , , , , , , - Biological Psychiatry 2006 cited by 516